Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 33

Sort by

Sort Order Select

Journal Articles

Mir-181c Modulates T Cell Function By Regulating the Expression of BRK1

Shok Ping Lim, Donal McLornan, MB, Bch (Hons), PhD MRCP, FRCPath, Nikolaos Ioannou, David Darling, Alan G. Ramsay, PhD, Joop Gäken, PhD, Ghulam J Mufti, MBBS, DM, FRCP, FRCPath

Blood (2016) 128 (22): 132.

https://doi.org/10.1182/blood.V128.22.132.132

Published: 2016

Journal Articles

Telomere Length and Telomerase Assay Assist in Identifying Novel Telomere Gene Complex Mutations in a Cohort of Patients with Aplastic Anemia

Shreyans Gandhi, MBBS,MDDNB,MRCP,FRCPath, Jie Jiang, PhD, Nana Benson-Quarm, B.Sc, Dip (Nursing), Hanna Renshaw, MBBS, MA, Syed A Mian, BSc, M.Phil, Austin G. Kulasekararaj, MBBS, MD MRCP, FRCPath, Ghulam J Mufti, MBBS, DM, FRCP, FRCPath, Judith C. W. Marsh, MD FRCP, FRCPath

Blood (2015) 126 (23): 667.

https://doi.org/10.1182/blood.V126.23.667.667

Published: 2015

Journal Articles

Kings Health Partners 17 Gene Amplicon Panel for Next Generation Sequencing One Stop Mutational Assessment In Myeloid Malignancies

Nicholas C Lea, PhD, Atiyeh Abdallah, PhD, Aytug Kizilors, PhD, Alexander E Smith, PhD, Syed A Mian, Azim M Mohamedali, PhD, Ghulam J Mufti, MBBS, DM, FRCP, FRCPath

Blood (2011) 118 (21): 748.

https://doi.org/10.1182/blood.V118.21.748.748

Published: 2011

Journal Articles

Myelodysplasia (MDS) patients' Experiences with Blood Transfusions

James Twiss, BSc, Stephen P McKenna, PhD, CPsychol, AFBPsS, Sigrid Rebecca Crawford, MSc, Jeanette N Wilburn, MSc, Kevin Loth, Ghulam J Mufti, MBBS, DM, FRCP, FRCPath

Blood (2011) 118 (21): 5033.

https://doi.org/10.1182/blood.V118.21.5033.5033

Published: 2011

Journal Articles

Investigation of the Impact of Myelodysplasia (MDS) From the Patients' Perspective

Stephen P McKenna, PhD, CPsychol, AFBPsS, James Twiss, BSc, Jeanette N Wilburn, MSc, Sigrid Rebecca Crawford, MSc, Kevin Loth, Ghulam J Mufti, MBBS, DM, FRCP, FRCPath

Blood (2011) 118 (21): 5049.

https://doi.org/10.1182/blood.V118.21.5049.5049

Published: 2011

Journal Articles

Influence of Karyotype On Overall Survival in Patients with Higher-Risk Myelodysplastic Syndrome Treated with Azacitidine or a Conventional Care Regimen.

Ghulam J Mufti, MBBS, DM, FRCP, FRCPath, Steven D. Gore, MD, Valeria Santini, MD, Pierre Fenaux, MD, PhD, Lewis R. Silverman, MD, Anne Hagemeijer, MD, Barry Skikne, MD, Eva Hellstrom-Lindberg, MD, PhD, John F. Seymour, MBBS, PhD, FRACP, CL Beach, PharmD, Jay Backstrom, MD, MPH, Indrasiri Fernando, PhD

Blood (2009) 114 (22): 1755.

https://doi.org/10.1182/blood.V114.22.1755.1755

Published: 2009

Journal Articles

Inborn Genomic Variation as Predisposing Factors to Myeloid Malignancies.

Christine O'Keefe, PhD, Bartlomiej P Przychodzen, Azim M Mohamedali, PhD, Ghulam J Mufti, MBBS, DM, FRCP, FRCPath, Michael McDevitt, Jaroslaw P. Maciejewski, MD, PhD

Blood (2009) 114 (22): 1590.

https://doi.org/10.1182/blood.V114.22.1590.1590

Published: 2009

Journal Articles

Acquired Somatic Uniparental Disomy is a Chromosomal Defect Important in Predicting Treatment Responses and Survival Outcomes in MDS, MDS/MPN and Secondary AML.

Ramon V. Tiu, MD, Christine O'Keefe, PhD, Lukasz P. Gondek, MD, Azim M. Mohamedali, PhD, Bartlomiej P. Przychodzen, Ghulam J. Mufti, MBBS, DM, FRCP, FRCPath, Mikkael A. Sekeres, MD, MS, Anjali S. Advani, Michael A. McDevitt, MD, PhD, Jaroslaw P. Maciejewski, MD, PhD

Blood (2009) 114 (22): 2630.

https://doi.org/10.1182/blood.V114.22.2630.2630

Published: 2009

Journal Articles

Evidence for A Macromolecular Complex in Poor Prognostic CLL That Contains CD38, CD49d, CD44, MMP-9 and ZAP-70.

Andrea Gail Sherman Buggins, Ph.D., Ana Levi, B.Sc., Satyen Gohil, MBBS, B.Sc., Keith Fishlock, MSc, Piers EM Patten, BSc, MRCP, MRCPath, Deborah Yallop, BSc, FRCPath, MB, BS, MRCP, Ghulam J Mufti, MBBS, DM, FRCP, FRCPath, Stephen Devereux, FRCP, FRCPath

Blood (2009) 114 (22): 2334.

https://doi.org/10.1182/blood.V114.22.2334.2334

Published: 2009

Journal Articles

Dual Src/Abl Kinase Targeted Inhibition in Myeloma Microenvironment Promotes Myeloma Cell Apoptosis Both in Vitro and In Vivo .

Karthik Ramasamy, Lee Macpherson, Ghulam J Mufti, MBBS, DM, FRCP, FRCPath, Stephen Schey, Yolanda Calle, Ph.D.

Blood (2009) 114 (22): 2813.

https://doi.org/10.1182/blood.V114.22.2813.2813

Published: 2009

Journal Articles

Comparative Analysis of Sibling Donor Reduced Intensity Conditioning Regimen for High Risk AML/MDS Using Anti-Thymocyte Globulin Versus Alemtuzumab for T-Cell Depletion.

ZiYi Lim, MD, Sarah Bennett, Aloysius YL Ho, MBBS, FRCP, FRCPath, Austin G Kulasekararaj, Sunil Gupta, MBBS, MRCP, Michelle Kenyon, BSc, RN, Janet Hayden, Judith C W Marsh, Antonio Pagliuca, MBBS, FRCP, FRCPath, MA, Ghulam J Mufti, MBBS, DM, FRCP, FRCPath

Blood (2009) 114 (22): 3362.

https://doi.org/10.1182/blood.V114.22.3362.3362

Published: 2009

Journal Articles

Therapy Related Myelodysplastic Syndrome and Acute Myeloid Leukaemia (tMDS/tAML) in Patients Treated with Purine Analogues (PA) for Lymphoproliferative Disorders (LPD); An Association with Alkylator Combination, Dose and Previous Alkylator Therapy.

Pallavi Kalkur, MRCP, Stella J Bowcock, FRCP, FRCPath, Anand Sharma, MRCP, Evangelia Dimitriadou, Ghulam J Mufti, MBBS, DM, FRCP, FRCPath, Saad M.B. Rassam, MD, FRCP, FRCPath

Blood (2009) 114 (22): 3828.

https://doi.org/10.1182/blood.V114.22.3828.3828

Published: 2009

Journal Articles

Prevalence of 46/1 JAK2 Haplotype in Patients with Budd-Chiari Syndrome with and without JAK2V617F and TET2 Mutations.

Nicholas C Lea, PhD, Lara N Roberts, Raj K Patel, Rachel Westbrook, Michael A Heneghan, Azim M Mohamedali, PhD, Alex E Smith, Atiyeh Abdallah, Nigel Westwood, PhD, CSci, FIBMS, Trisevgeni Kontou, Deborah Yallop, BSc, FRCPath, MB, BS, MRCP, Roopen Arya, Antonio Pagliuca, MBBS, FRCP, FRCPath, MA, Joop Gaken, PhD, Nigel D Heaton, Ghulam J Mufti, MBBS, DM, FRCP, FRCPath

Blood (2009) 114 (22): 434.

https://doi.org/10.1182/blood.V114.22.434.434

Published: 2009

Journal Articles

Deep Sequencing the Tet2 Gene in 360 Patients with Myeloid Neoplasms Provides a Comprehensive and Quantitative Mutation Map and Reveals Low Level Mutant Clones.

Alexander E Smith, Azim M Mohamedali, PhD, Syed a Mian, Technician, Nicholas C Lea, BSc, PhD, Nigel Westwood, PhD, CSci, FIBMS, Austin G Kulasekararaj, Joop Gaken, PhD, Corinna Strupp, Norbert Gattermann, MD, PhD, Ulrich Germing, Ghulam J Mufti, MBBS, DM, FRCP, FRCPath

Blood (2009) 114 (22): 733.

https://doi.org/10.1182/blood.V114.22.733.733

Published: 2009

Journal Articles

RBC Transfusion Independence and Safety Profile of Lenalidomide 5 or 10 mg in Pts with Low- or Int-1-Risk MDS with Del5q: Results From a Randomized Phase III Trial (MDS-004).

Pierre Fenaux, Aristotle Giagounidis, Dominik Selleslag, MD, Odile Beyne-Rauzy, MD, PhD, Ghulam J Mufti, MBBS, DM, FRCP, FRCPath, Moshe Mittelman, MD, Petra Muus, MD, PhD, Peter te Boekhorst, MD, PhD, Guillermo Sanz, MD, PhD, Consuelo del Cañizo, Agnes Guerci-Bresler, Brigitte Schlegelberger, M.D., Carlo Aul, Hans Kreipe, MD, Gudrun Goehring, Robert Knight, MD, John Francis, Tommy Fu, Eva Hellstrom-Lindberg, MD, PhD

Blood (2009) 114 (22): 944.

https://doi.org/10.1182/blood.V114.22.944.944

Published: 2009

Journal Articles

Mobilized Peripheral Blood Stem Cells (PBSC) Compared with Bone Marrow (BM) as the Stem Cell Source for Unrelated Donor Allogeneic Transplantation with Reduced Intensity Conditioning (RIC-alloSCT) in Patients with Acute Myeloid Leukemia (AML) in Complete Remission (CR): a Retrospective Analysis From the ALWP of EBMT.

Arnon Nagler, Myriam Labopin, Avichai Shimoni, Dietger Niederwieser, Nadezda Basara, Ghulam J Mufti, MBBS, DM, FRCP, FRCPath, Axel R. Zander, Renate Arnold, MD, Hildegard Greinix, Jan J. Cornelissen, MD, PhD, Graham H Jackson, MD, Charles Craddock, BM, DPhil, FRCP, FRCPath, Donald W. Bunjes, MD, PhD, Arnold Ganser, MD, Nigel H. Russell, MD, Slawomira Kyrcz-Krzemien, Mohamad Mohty, MD, PhD, Vanderson Rocha, MD, PhD

Blood (2009) 114 (22): 527.

https://doi.org/10.1182/blood.V114.22.527.527

Published: 2009

Journal Articles

Contrasting Roles of Th1 and Th17 Cells in Aplastic Anaemia (AA) and Myelodysplastic Syndrome (MDS).

Shahram Y Kordasti, MD, Sufyan M AlKhan, Ziyi Lim, Pilar Perez Abellan, Judith C W Marsh, Ghulam J Mufti, MBBS, DM, FRCP, FRCPath

Blood (2009) 114 (22): 1090.

https://doi.org/10.1182/blood.V114.22.1090.1090

Published: 2009

Journal Articles

Comparison of Low Dose Total Body Irradiation (TBI)-Based Reduced Intensity Conditioning (RIC) Vs. Chemotherapy-Based RIC Prior to Allogeneic Stem Cell Transplantation (allo-SCT) From An HLA Identical Sibling Donor for Acute Myeloid Leukemia (AML) in First Complete Remission (CR1): a Retrospective Analysis of 1200 Patients From the Acute Leukemia Working Party of EBMT.

Mohamad Mohty, MD, PhD, Myriam Labopin, Jeroen JWM Janssen, MD, Ghulam J Mufti, MBBS, DM, FRCP, FRCPath, J. J. Cornelissen, Noel-Jean Milpied, MD, Henrik Sengeloev, Didier Blaise, MD, Eefke Petersen, MD, Hakan Goker, John G. Gribben, Arnon Nagler, Vanderson Rocha, MD, PhD

Blood (2009) 114 (22): 1190.

https://doi.org/10.1182/blood.V114.22.1190.1190

Published: 2009

Journal Articles

Late Relapses Following Reduced Intensity Conditioning Allogeneic Haematopoietic Stem Cell Transplantation for Myeloid Malignancies Can Be Effectively Salvaged with Intensive Chemotherapy Followed by Cellular Therapy.

Austin Gladston Kulasekararaj, MBBS, MD, MRCP, FRCP, Ziyi Lim, Pramila Krishnamurthy, M. Mansour Ceesay, MRCP, FRCPath, Michelle Kenyon, BSc, RN, Janet Hayden, Judith C W Marsh, Aloysius YL Ho, MBBS, FRCP, FRCPath, Antonio Pagliuca, MBBS, FRCP, FRCPath, MA, Ghulam J Mufti, MBBS, DM, FRCP, FRCPath

Blood (2009) 114 (22): 2265.

https://doi.org/10.1182/blood.V114.22.2265.2265

Published: 2009

Journal Articles

A Decade of Reduced-Intensity Conditioned Allogeneic Haematopoietic Stem Cell Transplantation for Myelodysplastic Syndromes Following Conditioning with Fludarabine, Busulphan and Alemtuzumab.

Aloysius YL Ho, MBBS, FRCP, FRCPath, Pramila Krishnamurthy, ZiYi Lim, MD, Michelle Kenyon, BSc, RN, Aleksander Mijovic, FRCPath, Stephen Devereux, FRCP, FRCPath, Antonio Pagliuca, MBBS, FRCP, FRCPath, MA, Ghulam J Mufti, MBBS, DM, FRCP, FRCPath

Blood (2009) 114 (22): 2266.

https://doi.org/10.1182/blood.V114.22.2266.2266

Published: 2009

NARROW

Mir-181c Modulates T Cell Function By Regulating the Expression of BRK1

Telomere Length and Telomerase Assay Assist in Identifying Novel Telomere Gene Complex Mutations in a Cohort of Patients with Aplastic Anemia

Kings Health Partners 17 Gene Amplicon Panel for Next Generation Sequencing One Stop Mutational Assessment In Myeloid Malignancies

Myelodysplasia (MDS) patients' Experiences with Blood Transfusions

Investigation of the Impact of Myelodysplasia (MDS) From the Patients' Perspective

Influence of Karyotype On Overall Survival in Patients with Higher-Risk Myelodysplastic Syndrome Treated with Azacitidine or a Conventional Care Regimen.

Inborn Genomic Variation as Predisposing Factors to Myeloid Malignancies.

Acquired Somatic Uniparental Disomy is a Chromosomal Defect Important in Predicting Treatment Responses and Survival Outcomes in MDS, MDS/MPN and Secondary AML.

Evidence for A Macromolecular Complex in Poor Prognostic CLL That Contains CD38, CD49d, CD44, MMP-9 and ZAP-70.

Dual Src/Abl Kinase Targeted Inhibition in Myeloma Microenvironment Promotes Myeloma Cell Apoptosis Both in Vitro and In Vivo .

Comparative Analysis of Sibling Donor Reduced Intensity Conditioning Regimen for High Risk AML/MDS Using Anti-Thymocyte Globulin Versus Alemtuzumab for T-Cell Depletion.

Therapy Related Myelodysplastic Syndrome and Acute Myeloid Leukaemia (tMDS/tAML) in Patients Treated with Purine Analogues (PA) for Lymphoproliferative Disorders (LPD); An Association with Alkylator Combination, Dose and Previous Alkylator Therapy.

Prevalence of 46/1 JAK2 Haplotype in Patients with Budd-Chiari Syndrome with and without JAK2V617F and TET2 Mutations.

Deep Sequencing the Tet2 Gene in 360 Patients with Myeloid Neoplasms Provides a Comprehensive and Quantitative Mutation Map and Reveals Low Level Mutant Clones.

RBC Transfusion Independence and Safety Profile of Lenalidomide 5 or 10 mg in Pts with Low- or Int-1-Risk MDS with Del5q: Results From a Randomized Phase III Trial (MDS-004).

Contrasting Roles of Th1 and Th17 Cells in Aplastic Anaemia (AA) and Myelodysplastic Syndrome (MDS).

Late Relapses Following Reduced Intensity Conditioning Allogeneic Haematopoietic Stem Cell Transplantation for Myeloid Malignancies Can Be Effectively Salvaged with Intensive Chemotherapy Followed by Cellular Therapy.

A Decade of Reduced-Intensity Conditioned Allogeneic Haematopoietic Stem Cell Transplantation for Myelodysplastic Syndromes Following Conditioning with Fludarabine, Busulphan and Alemtuzumab.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only